Neuropsychology and clinical neuroscience of persistent post-concussive syndrome.

J Int Neuropsychol Soc

Department of Psychology, Brigham Young University, Provo, Utah 84602, USA.

Published: January 2008

On the mild end of the acquired brain injury spectrum, the terms concussion and mild traumatic brain injury (mTBI) have been used interchangeably, where persistent post-concussive syndrome (PPCS) has been a label given when symptoms persist for more than three months post-concussion. Whereas a brief history of concussion research is overviewed, the focus of this review is on the current status of PPCS as a clinical entity from the perspective of recent advances in the biomechanical modeling of concussion in human and animal studies, particularly directed at a better understanding of the neuropathology associated with concussion. These studies implicate common regions of injury, including the upper brainstem, base of the frontal lobe, hypothalamic-pituitary axis, medial temporal lobe, fornix, and corpus callosum. Limitations of current neuropsychological techniques for the clinical assessment of memory and executive function are explored and recommendations for improved research designs offered, that may enhance the study of long-term neuropsychological sequelae of concussion.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S135561770808017XDOI Listing

Publication Analysis

Top Keywords

persistent post-concussive
8
post-concussive syndrome
8
brain injury
8
concussion
5
neuropsychology clinical
4
clinical neuroscience
4
neuroscience persistent
4
syndrome mild
4
mild acquired
4
acquired brain
4

Similar Publications

Introduction: Athletes with concussions experience heterogeneous symptoms and clinical trajectories. Subclassification provides diagnostic clarity that may improve prognostication and individualized treatments.

Methods: We hypothesized that endophenotypes of adolescent athletes with concussions differ based on sex and time since injury.

View Article and Find Full Text PDF

Evaluating a 12-week aerobic exercise intervention in adults with persisting post-concussive symptoms.

Front Neurol

December 2024

Department of Clinical Neurosciences, Division of Physical Medicine and Rehabilitation, University of Calgary, Calgary, AB, Canada.

Background: Although guidelines support aerobic exercise in sub-acute mild traumatic brain injury (mTBI), evidence for adults with persisting post-concussive symptoms (PPCS) after mTBI is lacking. The objective was to evaluate the impact of a sub-symptom threshold aerobic exercise intervention on overall symptom burden and quality of life in adults with PPCS.

Methods: This prospective cohort study was nested within the ACTBI Trial (Aerobic Exercise for treatment of Chronic symptoms following mild Traumatic Brain Injury).

View Article and Find Full Text PDF

Traumatic brain injury (TBI) is frequently associated with hypopituitarism. The hypothalamic-pituitary axis appears to be susceptible to the same forces that cause injury to the parenchyma of the brain. Following even a mild TBI (mTBI), patients may suffer transient or permanent decreases in anterior pituitary hormones, including somatotropin (growth hormone [GH]), gonadotropins (luteinizing hormone and follicle-stimulating hormone), thyrotropin, and adrenocorticotropic hormone, with the most frequent long-term deficiency being GH deficiency (GHD).

View Article and Find Full Text PDF

Background: A significant portion of youth sustain a concussion every year, with around 30% experiencing persistent post-concussion symptoms (PPCS). Research has shown exercising just below the exertion level that provokes symptoms can lead to more rapid recovery. However, youth often struggle to adhere to exercise recommendations following concussion.

View Article and Find Full Text PDF
Article Synopsis
  • The CONCUSS trial is a randomized clinical trial aimed at comparing the effectiveness of immediate office-based vergence/accommodative therapy with delayed therapy for treating concussion-related convergence insufficiency in young people aged 11-25.
  • The study involves enrolling 100 participants and assessing outcomes after both immediate and delayed treatments, focusing on changes in convergence abilities and symptoms.
  • Key elements of the study include clear definitions of conditions, standardized protocols, a delayed treatment group, and the use of advanced measures like eye movement recording and brain imaging to evaluate the treatments' effects.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!